Condition
Advanced Malignant Mesothelioma|Epithelial Mesothelioma|Localized Malignant Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatous Mesothelioma
Estimated Enrollment: 51
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: NCI-2009-00126|N01CM17102|CDR0000463521|14203B
Study First Received: March 29, 2006
Last Updated: July 25, 2014
Estimated Primary Completion Date: September 2010
Primary Outcome Measures:
Objective Response Rate, Complete (CR) or Partial (PR) Response|Changes in Laboratory Correlates|Pharmacogenomics by Correlating Genetic Polymorphisms With Drug Activity and Toxicity
Sponsors and Collaborators:
National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00309946
